›Immediate stabilization
›Cardiac monitor if unstable
›IV access if sepsis concern
›Fluids if hypovolemia and no contraindication
›Broad spectrum antibiotics if sepsis suspected local protocol dependent
›Catheterization pathway
›Urethral Foley catheter
›Initial 14 to 18 Fr typical adult size
›Coude catheter if prostatic obstruction suspected
›Drainage monitoring
›Immediate urine output volume
›Hematuria after insertion
›Bladder decompression complications
›Post obstructive diuresis monitoring
›Hypotension after decompression uncommon
Etiology directed treatment
›Benign prostatic hyperplasia suspected
›Alpha blocker example
›Tamsulosin PO 0.4 mg daily
›Orthostatic hypotension risk
›Trial of void timing local protocol dependent
›2 to 3 days after alpha blocker start common practice
›Earlier trial may fail
›Urinary tract infection suspected
›Antibiotics local protocol dependent
›Tailor to local antibiogram
›Adjust for renal function
›Pyelonephritis or sepsis concern
›Parenteral antibiotics local protocol dependent
›Admission consideration
›Constipation contribution
›Disimpaction strategy local protocol dependent
›Osmotic laxative example
›Polyethylene glycol PO 17 g daily
›Avoid if bowel obstruction concern
›Cauda equina syndrome concern
›Immediate MRI spine
›Neurosurgery consultation emergent
›Reassessment timing
›Pain reassessment within 30 to 60 minutes
›Urine output reassessment within 1 hour
›Repeat bladder scan if poor catheter drainage
›Post obstructive diuresis monitoring
›Urine output > 200 mL per hour for 2 hours
›Or > 3 L in 24 hours
›Electrolytes every 4 to 6 hours if significant diuresis